RSH USA, INC. – Trademark Portfolio
Entity Type: 03
RSH USA, INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ORB HEALTH. The owner is based in MELBOURNE.
SUITE 1, LEVEL 9, 432 ST KILDA RD.
MELBOURNE 3004 , AU
Showing of trademarks Trademarks
Trademark Classifications
RSH USA, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does RSH USA, INC. have?
RSH USA, INC. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does RSH USA, INC. file in?
RSH USA, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are RSH USA, INC.'s most well-known trademarks?
RSH USA, INC.'s registered trademark portfolio includes well-known marks such as ORB HEALTH. These are among 1 currently registered trademark in the portfolio.
What is RSH USA, INC.'s trademark registration success rate?
RSH USA, INC. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.